Kurtis Ng

Kurtis Ng

Auto-generated profile, based on publicly available information

Kurtis Ng

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2026 in Science
Verified
Journal Article
Closed access
MAMatthew J. Anketell
Matthew J. Anketell
EFEthan Fung
Ethan Fung
WLWenbin Liu
Wenbin Liu
MSMahesh Shinde
Mahesh Shinde
CHCyndi Qixin He
Cyndi Qixin He
RBRobert Britton
Robert Britton
Nucleoside analogs (NAs) are essential as antiviral and anticancer therapies. Despite decades of focused medicinal chemistry efforts, their related chemical space remains underexplored, mainly owing to their lengthy, single-molecule–oriented syntheses that lack the flexibility required to generate NA libraries. Here we report a flexible, robust, and efficient platform for the high-throughput synthesis of NAs using a photoredox coupling strategy. This approach produces both carbon- and nitrogen-linked NAs and unifies the synthesis of several disparate NA classes, including 4′-thio, 4′-imino, and ProTides, all from a simple, scalable intermediate. Using this platform, we demonstrate the production of a diverse NA library and identify several hit compounds with anti–HIV-1 activity. We expect that this newly developed approach to NAs will inspire and support drug discovery efforts in this area.

6 May 2025 in Chemistry – A European Journal
Verified
Journal Article
Open access
OMOscar Javier Gamboa Marin
Oscar Javier Gamboa Marin
KNKurtis Ng
Kurtis Ng
NVNitish Verma
Nitish Verma
AYAssi Gérard Flavien Yapi
Assi Gérard Flavien Yapi
Ralph PantophletRalph Pantophlet
Ralph Pantophlet
CGCharles Gauthier
Charles Gauthier
Blocking dendritic cell‐specific intercellular adhesion molecule‐3‐grabbing nonintegrin (DC‐SIGN)‐ and liver/lymph node‐specific intercellular adhesion molecule‐3‐grabbing integrin (L‐SIGN)‐mediated human immunodeficiency virus 1 (HIV‐1) attachment to immune cells represents a promising strategy for developing antiretroviral agents effective during the early stages of sexual transmission. Although mannose‐ and fucose‐based ligands have received considerable attention, Lewis‐based inhibitors remain relatively underexplored. In this study, we report the first synthesis of Lewis‐X‐containing triterpenoid saponins featuring betulinic acid and echinocystic acid as aglycones. These saponins were stereoselectively and efficiently synthesized in six linear steps using a convergent approach that leveraged thioglycoside and trichloroacetimidate glycosylation chemistries. Notably, our findings demonstrate that these Lewis‐X‐containing triterpenoid saponins are among the most potent monovalent inhibitors reported to date of DC‐SIGN‐ and L‐SIGN‐mediated transfer of HIV‐1 infection to CD4‐positive cells, with IC50 values in the low micromolar range (21–50 µM). This work lays a valuable foundation for the development of saponin‐based antiviral agents targeting immune cells.

11 February 2022 in ChemBioChem
Verified
Journal Article
Open access
PDF file
MCMatteo Cattin
Matteo Cattin
JBJean‐François Bruxelle
Jean‐François Bruxelle
KNKurtis Ng
Kurtis Ng
MBMarkus Blaukopf
Markus Blaukopf
Ralph PantophletRalph Pantophlet
Ralph Pantophlet
PKPaul Kosma
Paul Kosma
Oligomannose‐type glycans on the spike protein of HIV‐1 constitute relevant epitopes to elicit broadly neutralizing antibodies (bnAbs). Herein we describe an improved synthesis of α‐ and β‐linked hepta‐ and nonamannosyl ligands that were subsequently converted into BSA and CRM197 neoglycoconjugates. We assembled the ligands from anomeric 3‐azidopropyl spacer glycosides from select 3‐O‐protected thiocresyl mannoside donors. Chain extensions were achieved using [4+3] or [4+5] block synthesis of thiocresyl and trichloroacetimidate glycosyl donors. Subsequent global deprotection generated the 3‐aminopropyl oligosaccharide ligands. ELISA binding data obtained with the β‐anomeric hepta‐ and nonamannosyl conjugates with a selection of HIV‐1 bnAbs showed comparable binding of both mannosyl ligands by Fab fragments yet lesser binding of the nonasaccharide conjugate by the corresponding IgG antibodies. These results support previous observations that a complete Man9 structure might not be the preferred antigenic binding motif for some oligomannose‐specific antibodies, and have implications for glycoside designs to elicit oligomannose‐targeted HIV‐1‐neutralizing antibodies.